INTRODUCTION
N2-(p-n-Butylphenyl)-2 '-deoxyguanosine 5' -triphosphate (butylphenyl-dGTP, BuPdGTP) is a potent and selective inhibitor of eukaryotic DNA polymerase at and a-like DNA polymerases such as bacteriophage T4 DNA polymerase. [1] [2] [3] [4] In contrast, E. coli DNA polymerase I (pol I) has been found to be quite insensitive to this nucleotide.4 BuPdGTP is not a substrate for DNA polymerase a, but appears to be a substrate for the T4 enzyme.2 Thus, the basis for sensitivity to BuPdGTP among DNA polymerases may be complex.
Among a series of N2-substituted dGTP derivatives, we recently reported that N2-phenyl-dGTP (and BuPdGTP) could be incorporated by E. coli DNA polymerase I into an oligodeoxyribonucleotide primer in place of dGTP, but that significant chain termination occurred at the incorporation sites. 5 In order to study the effects of butylphenyl-dG residues at the primer terminus on BuPdGTP-sensitive (pol a, T4 pol) and insensitive (pol I) enzymes, and to have authentic material for comparison of the properties of enzymatically incorporated BuPdGTP, we have synthesized chemically a 3'-BuPdGoligomer. We show that the properties of this oligomer annealed to a complementary template are identical with those of the oligomer into which BuPdGTP has been incorporated by pol l, namely that the BuPdG-oligomer cannot be extended with the next substrate and cannot be degraded by the 3' to 5' exonuclease activity of pol I.
MATERIALS AND METHODS

Syntheses
General. NMR spectra were determined with a Varian Unity 300 instrument. Chemical shifts in 'H spectra at 300 MHz are referred to internal TMS, and in 31p spectra at 121.4 MHz to a capillary of 1% phosphoric acid. S '-(Dimethoxytrityl)-N2-(p-n-butylphenyl)-9-(2-deoxy-,3-Dribofiuranosyl)guanine (5'-DMT-BuPdG, 2). Triethylamine (200 AL) was added to a solution of N2-(p-n-Butylphenyl-9-(2-deoxy-f3-D-ribofuranosyl)guanine (BuPdG, 1)6 (145 mg, 0.363 mmol), dimethoxytrityl chloride (493 mg, 1.45 mmol) and 4-(dimethylamino)pyridine (1.3 mg) in dry pyridine (5 mL). After stirring for 2 hr at rt under Ar, the solution was poured into sat. NaHCO3 solution. This mixture was extracted with ethyl acetate (3 x 5 mL), and the dried (Na2SO4) organic phase was concentrated and the residue applied to a silica gel column (51 x2 cm). After washing with CHCl3 the product was eluted with CHCl3:MeOH (20:1). After evaporation of solvents the product was crystallized from MeOH giving 161 mg (61 %) of 2 as colorless crystals, mp 165-170°C. Anal. (C41H43N506): Calcd. C, 70.17; H, 6.18; N, 9. 98. Found C, 69.98; H, 6.17; N, 9.90 . 'H NMR (Me2SO-d6) 6 6.26 (t, 1'H), 4 .37 (m, 3'H), 5.31 (d, exch, 3'-OH), 3.2 (d, 5',5"H).
5'-(Dimethoxytrityl)-N2-(p-n-butylphenyl)-9-(2-deoxy-,B-Dribofuranosyl)guanine-3 '-H-phosphonate, triethylammonium salt (3). 1,2,4-Triazole (21.7 mg, 1.18 mmol) was added to a stirred solution of PCl3 (48.9 mg, 0.35 mmol) and N-methylmorpholine (39.2 IL, 3.6 mmol) in dry CH2C12, and the mixture was stirred for 2 h at rt under argon.7 The mixture was cooled to -5°C, and a solution of 2 (50 mg, 0.71 mmol) in dry CH2CI2 (3 mL) was added slowly. After 20 min at -5°C the reaction mixture was poured into 10 mL of 1M triethylammonium bicarbonate (TEAB, pH 8.5). The organic layer was separated, and the aqueous phase was extracted with CH2C12 (10 mL). The combined organic extracts were dried (Na2SO4) and the solvents removed to give a gum. This material was dissolved in CHC13 (0.5 mL), and the solution was slowly added to pentane (25 mL) cooled to -78°C. The colorless precipitate was collected by filtration to give 60 mg (97%) of 3. Analytically pure product was obtained by silica gel chromatography (10 x 2 cm; prepared in 1% NEt3 in CHC13) and elution with 5% MeOH in CHC13 (81% recovery). Anal. (C47H59N608P): Calcd. P, 3.57. Found P, 3.25. NMR (CD3CN:C6D5N, 1:1): 'H 6 7.17 (d, J=608.5
Hz, PH), 6.46 (t, l'H), 5.29 (m, 3'H), 3 .52 (d, 5',5"-H). 31p 6 -3.05, IJPH=608.5 Hz, 4JPH=9.15 Hz.
3'-BuPdG-l8mer (9) . The oligodeoxyribonucleotide was synthesized via the H-phosphonate approach using an automated DNA synthesizer (8700 model, Millipore, Milford, MA).
Synthesis was carried out on a 1 Amol scale using the Hphosphonate coupling cycle.8 The first step coupled the BuPdG-H-phosphonate (3) to uridine-controlled pore glass (CPG) support (Glen Research, Herndon, VA) with pivaloyl chloride catalyst. The required oligonucleotide sequence was assembled onto the CPG-bound dinucleoside H-phosphonate (4) with 5'-DMT-2'deoxyribonucleoside-3'-H-phosphonates (4.0 mg/coupling). 7, 8 At the end of the assembly, the CPG-bound oligonucleotide H-phosphonate (5) was oxidized with 2% 12 in pyridine:water (98:2, v:v) for 10 min to generate the phosphodiester backbone. Deprotection was carried out in conc NH40H for 10 hr at 55°C. Ammonia was removed by evaporation, and the solid mass of 6 was suspended in 1 mL of water.
The crude oligonucleotide suspension was treated with sodium periodate in sodium acetate buffer, pH 5.5, for 30 min in the dark at ambient temperature. The progress of the reaction was followed by reverse phase HPLC9 (see below). The reaction mixture was desalted using a Sep-pak C-18 cartridge (Waters Associates, Milford, MA), and the eluate containing the dialdehyde form of the oligonucleotide (7) was treated with cyclohexylamine to remove uridine by $-elimination. The product, the 3'-phosphate of the oligodeoxyribonucleotide (8), was incubated with bacterial alkaline phosphatase to obtain the free BuPdG-18mer (9), which was purified by electrophoresis in a 8M urea-polyacrylamide gel.
HPLC. Analytical HPLC was carried out using a Waters 
RESULTS
Chemistry
We used H-phosphonate chemistry and a uridine-controlled pore glass (CPG) conjugate for synthesis of an oligomer containing the N2-(p-n-butylphenyl)dGuo residue at the 3' position (Chart I). This strategy was dictated, in part, by our inability to prepare the 3'-hemisuccinate of 5'-DMT-BuPdG for direct attachment to aminoalkyl-CPG (data not shown). 5'-DMT-BuPdG (2) and its 3'-H-phosphonate (3) were synthesized by standard methods.7 The H-phosphonate was obtained in 97% yield and was characterized by IH and 31P NMR and P analysis (see Materials and Methods). Oligodeoxyribonucleotide synthesis was performed on a DNA synthesizer by reported procedures.7,8 Compound 3 was coupled to uridine-CPG with pivaloyl chloride (Chart I, step c). The chain was elongated with protected 5'-DMT-deoxynucleoside 3'-Hphosphonates, and the CPG-bound oligonucleoside-Hphosphonate was oxidized with iodine (step d) to generate the oligonucleotide phosphodiester, 5. (The boldface sequence in structure 5, Chart I, implies protected bases.) After deprotection of the bases and release from CPG (step e), the free uridinecapped oligonucleotide (6) was treated with periodic acid at room temperature (step f) to generate the dialdehyde, 7.9 After desalting on a C-18 column the dialdehyde was treated with cyclohexylamine (step g) to effect f-elimination to yield the BuPdG-1 8mer as the 3 '-phosphate, 8. After dephosphorylation with bacterial alkaline phosphatase, the BuPdG-18mer, 9, was purified by denaturing polyacrylamide gel electrophoresis. The preparation was done on a 1 timole scale, and coupling efficiency was 98%. The ability of the BuPdG-18mer to serve as a substrate for dNTP incorporation was shown by the results of extension reactions with TdT. Incubation of BuPdG-1 8mer with TdT in the presence of dGTP or BuPdGTP at 50 pM for 60 min at 35°C gave products as shown in Figure 1 . The oligonucleotide gave BuPdGTP is a substrate for E.coli pol I
The primer-template illustrated in Figure 2 was used to monitor incorporation of nucleotides by E. coli pol l, Klenow fragment. 5'-32P-labelled 17mer primer, prepared with ['y-32P]ATP and polynucleotide kinase, was annealed to 29mer template as described previously.2 After incubation with pol I at 30°C for 10 minutes, the reaction mixtures were applied to a 8M urea-12% polyacrylamide gel and subjected to electrophoresis as described.2 As illustrated in Figure 2 , incubation with all dNTPs at 10,uM produced fully copied 29mer product (lane J). Inclusion of 2 AM dGTP alone (lane C) or 2 yM each of dGTP and dTTP (lane E) resulted in nearly exclusive conversion of primer to the expected 18mer and l9mer, respectively. When 17mer:29mer was incubated with pol I and 100 yM BuPdGTP alone, a product migrating at nearly the same position as the 18mer was observed (lane D). This produict appeared at the same position as 5/_32plabelled BuPdG-l8mer, synthesized as described above (lane B). Migration of the BuPdG-1 8mer in the gel was slightly slower than that of the conventional dG-l8mer (Figure 2 and results not shown). To determine the extent of this resistance, the BuPdG-18mer:29mer was incubated with dTTP and pol I under various conditions. Incubations at concentrations as high as 100 ,tM dTTP and for up to 60 minutes at 30°C did not lead to extension of the BuPdG-primer by pol I (data not shown).
3'-BuPdG primer is resistant to pol I 3' to 5' exonuclease In control extension reactions of the primer:templates lacking dNTP substrates, the 17mer primer was partially degraded by the 3' to 5' exonuclease activity of pol l, but no such degradation was observed with the BuPdG-1 8mer (results not shown).
Because exonucleolytic cleavage of single stranded DNA is more efficient than that of double stranded DNA,'2 we incubated labelled 17mer and BuPdG-18mer separately with pol I at 30°C and removed aliquots of the reactions at various times. The aliquots were subjected to denaturing PAGE with the results shown in Figure 3 . It is clear that the 17mer is degraded to smaller oligomers with a half life of about 15 minutes and that essentially none remains after 60 minutes. In contrast, no demonstrable degradation of the BuPdG-18mer was observed after incubation for 60 minutes (Figure 3 ).
BuPdGTP is a weak inhibitor of pol I and protects activated DNA from exonucleolytic degradation BuPdGTP was added to assays of pol I with activated DNA in the presence 25 /tM each of dATP, dCTP and dGTP, and the incorporation of 10 A M [3H]dTTP into acid-precipitable material was measured. Only 24% inhibition of label incorporation was observed at 100 ptM BuPdGTP under these conditions. In **' * *~~~~~~~~~~~~~~~~!s contrast, when pol I was assayed in the absence of dGTP (the truncated assay), BuPdGTP stimulated labelled dTTP incorporation at low concentrations (Table 1) . Because the results above showed that BuPdGTP is a terminating substrate for pol I, one would expect either no effect of the compound or inhibition rather than stimulation of enzyme activity in the truncated assay. The results are, however, consistent with two possibilities. First, BuPdGTP may inhibit the 3' to 5' exonuclease activity directly. The need for an authentic 3'-BuPdG oligomer to test hypotheses about the mechanism(s) of DNA polymerase inhibition by BuPdGTP prompted the chemical synthesis reported in this paper. E. coli DNA polymerase I has been considered resistant to BuPdGTP, based on the weak inhibition (see above) or lack of inhibition' observed in standard assays of the enzyme. In this paper we have shown that, in the absence of competing dGTP, BuPdGTP stimulates residual synthesis catalyzed by pol I in a truncated assay lacking dGTP, and is a substrate with surprisingly good affinity for the enzyme. The apparent Km values of 0.8 AM and 2.0 /tM for dGTP and BuPdGTP in single site extension reactions (see above) indicate similar affinities of the nucleotides for the enzyme-primer:template complex. However, the profoundly reduced incorporation rate of the modified substrate (see above) explains the apparent resistance of pol I activity toward the compound in standard assays containing dGTP. These results suggest that the BuPdG-primers, when formed, do not have substantial affinity for the enzyme. In contrast, the high potency of BuPdGTP for T4 DNA polymerase may result directly from incorporation of the analog. Our application of the primer extension reactions and synthetic BuPdG-primer:templates will help to clarify these issues.
